Ligand Pharmaceuticals is a biotechnology company focused on developing and commercializing innovative therapies for various diseases. Founded in 1992, the company specializes in using its proprietary technology platforms to discover and optimize drug candidates, particularly in the fields of oncology, neurology, and metabolic disorders. Ligand collaborates with other pharmaceutical companies to enhance drug development processes. Its portfolio includes a range of partnered programs and royalty-generating assets, which contribute to its revenue. The company is headquartered in San Diego, California, and is publicly traded on the NASDAQ stock exchange under the ticker symbol LGND.